Quantitative estimation of gemcitabine by HPLC in plasma

A method for estimating the antitumor agent gemcitabine in plasma by isocratic HPLC was developed. Sample preparation consisted of precipitating proteins with a mixture of acetonitrile and methanol (9:1) with subsequent acidification of the extract with glacial acetic acid. Supernatants were then evaporated to dryness in a rotary vacuum evaporator at 42°C. The dry residue was dissolved in the mobile phase, which consisted of a mixture of acetate buffer pH 5.0 and acetonitrile (97.5:2.5). UV detection of gemcitabine was performed at 282 nm. The detection limit for this compound was 1 μg/ml. This method can be used to study the pharmacokinetic characteristics of the agent within the frameworks of the protocol "Studies of dose-dependent regimes of long-term infusions of gemcitabine in patients with local and disseminated pancreas cancer". © 2008 Springer Science+Business Media, Inc.

Authors
Parshina N.A.1 , Pleteneva T.V. 2 , Baikova V.N.1 , Narimanov M.N.1 , Tyulyandin S.A.1
Number of issue
5
Language
English
Pages
288-290
Status
Published
Volume
42
Year
2008
Organizations
  • 1 N. N. Blokhin Russian Oncological Scientific Center, Russian Academy of Medical Sciences, Moscow, Russian Federation
  • 2 Russian University of the Friendship of the Peoples, Moscow, Russian Federation
Keywords
deoxycytidine; gemcitabine; analytic method; antineoplastic activity; article; controlled study; drug determination; drug structure; drug transformation; high performance liquid chromatography; human; human tissue; plasma; reproducibility
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/3115/
Share

Other records